Browsing: FDA

The FDA is preparing in case the current strain of avian flu circulating in the U.S. jumps to humans on a large scale, the agency’s commissioner told senators Wednesday. FDA Commissioner Robert Califf told the Senate Appropriations Committee that while the threat to humans is low and milk products are safe,…

The company in Cambridge that produces a drug for Lou Gehrig’s disease which recently didn't work in a big study stated Thursday it will pull the medication, Relyvrio, from the market, admitting it didn't benefit patients with the fatal neurological condition.

The FDA has issued a Class I recall, the highest-level alert, for heart pumps linked to nearly 50 deaths. Impella heart pumps are used for short term support of pumping blood in the heart’s ventricles during medical procedures or after a severe heart attack. The…

Medicare may cover the popular weight loss medication Wegovy if the patients also have heart disease and need to lower the risk of future heart attacks, strokes, and other serious issues, as stated by federal officials on Thursday.

The U.S. Food and Drug Administration (FDA) has approved the first drug to treat serious liver disease, the agency announced in a release Thursday. The FDA approved Rezdiffra (resmetirom) for the treatment of adults with a common form of liver inflammation called nonalcoholic steatohepatitis, or NASH. NASH, also known as metabolic dysfunction-associated steatohepatitis, or MASH,…

The U.S. Food and Drug Administration announced on Wednesday a recall of certain cashews sold at Walmart, after the manufacturer discovered cans were incorrectly labeled and therefore did not contain proper allergen warnings. John B. Sanfilippo & Son, Inc. (JBSS) issued a voluntary recall of certain Great Value Honey Roasted Cashews sold at Walmart stores.…

A judge in Texas has stopped a new rule from the National Labor Relations Board that would have made it simpler for many workers to create unions at large corporations.

Eli Lilly revealed that the FDA is postponing the approval of its new Alzheimer’s medication and insisting that the company present its safety and effectiveness data to an advisory panel for review. Lilly stated on Friday, "The FDA has told us it needs more insight into evaluating the…"

The first new treatment for the condition in 50 years

Conflicts of interest and a lack of regulation make these tests a costly gamble